table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 all comersCOVID-19 mild to moderate
COVID 19 hospitalizedCOVID 19 all comersCOVID-19 mild to moderate
potential COVID-19 treatments
adjuvant therapies
anticoagulant X-COVID-19
anticoagulant, curative dose COALIZAO ACTION ATTACC, ACTIV-4a, and REMAP-CAP ...
heparin at therapeutic dose RAPID ...
anti-inflammatoty and immuno-therapy
anti-inflammatory therapies
anti GM-CSF
mavrilimumab MASH-COVID ...
clarithromycine Rashad ...
colchicine COLCOVID Lopes MIF Salehzadeh GRECCO-19 RECOVERY ... Horby COL-COVID ...
Colchicine plus rosuvastatin COLSTAT Gaitan-Duarte ...
non-steroidal anti-inflammatory drugs Guzman-Esquivel
Indomethacin Ravichandran
stem cells Lanzoni Carmenate ...
corticosteroids GLUCOCOVID
dexamethasone RECOVERY dexamethasone
methylprednisolone Tang X Metcovid Ranjbar
Immunostimulants drugs
convalescent plasma treatment ConCOVID ... ConPlas-19 COP-COVID-19 CONTAIN COVID-19 PC/COVID-19 NCT04397757 PLACO-COVID CONCOR-1 CPC-SARS NCT04442191 DAWN-Plasma NCT04385199 COPLA-II trial NCT04403477 ... ASCOT RECOVERY ... CONFIDENT PERUCONPLASMA Bennett-Guerrero Salman Kirenga LACCPT Co-CLARITY NCT04528368 Holm K CCAP-2 Baldeon Menichetti LIFESAVER PLACID Libster
Early convalescent plasma. Balcells
immunoglobulin therapy Sakoulas Parikh
interferon
IFN beta-1a SOLIDARITY ...
high-dose IFN beta-1a Darazam
IFN gamma Esquivel-Moynelo
inhaled interferon
IFN alpha
pegylated interferon-α2b Pandit Shashi Bhushan
recombinant super-compound interferon rSIFN-co Li
SNG001 inhaled interferon beta Synairgen SG016 SPRINTER
interferon / TFF2 Fu
peginterferon Jagannathan
PNB001 Lattmann
neutralizing antibody ITAC
amubarvimab/romlusevimab (BRII-196 and BRII-198-Brii Biosciences) ACTIV-3 ...
bamlanivimab monotherapy ACTIV-3/TICO LY-CoV555
casirivimab/imdevimab (Ronapreve) RECOVERY ... Somersan-Karakaya ...
cilgavimab and tixagevimab (Evusheld) ACTIV-3/TICO ...
sotrovimab (Xevudy; VIR-7831) ACTIV-3/ TICO ...
Immunosuppressants drugs
anakinra SAVE-MORE CORIMUNO-ANA-1
anti-interleukin-6
sarilumab CORIMUNO-SARI-1 ...
sarilumab high dose (400mg) sarilumab phase 2 high dose
sarilumab low dose (200mg) sarimulab phase 2 low dose
tocilizumab Dongsheng Wang RCT-TCZ-COVID-19 EMPACTA RECOVERY Soin AS ... Rutgers NCT04412772 ... Declercq J ... NCT04577534 ... EU-CTR2020-001375-32 ... EU-CTR2020-001748-24 ... NCT04479358 ... NCT04434717 ... TOCOVID BACC Bay Tocilizumab Trial
canakinumab Sheng ...
janus kinase (JAK) inhibitor
baricitinib COV-BARRIER ACTT-2 ... RECOVERY
tofacitinib STOP-COVID ... Murugesan
lenzilumab LIVE-AIR ...
Kinase inhibitors
acalabrutinib CALAVI CALAVI US
imatinib Covid-19 HUF
leflunomide Wang et al. Wang
antiandrogenic
progesterone Ghandehari
proxalutamide Cadegiani
antiviral and associated therapy
azithromycin Sekhavati RECOVERY ... COALITION I Covid-19 Brazil ... Rashad A ...
azvudine Ren
baloxavir marboxil Lou Y
bromhexine Ansarin Tolouian Li T
chloroquine and derivatives
chloroquine Huang Chen, ChiCTR2000030054 - Chloroquine NCT04342650
hydroxychloroquine Tang HAHPS ORCHID Duke University hydroxychloroquine/azithromycine RECOVERY SOLIDARITY ... Chen NO COVID-19 ... Abd-Elsalam CCAP-1 Duke university HCQ ARCHAIC -hydroxychloroquine PROTECT B TEACH OAHU-COVID19 HYCOVID IRCT20200428047228N1 // U07 Gonzalez ... PROTECT A ChiCTR2000030054-HCQ ... IRCT20150808023559N20 IRCT20150808023559N20 NOR-Solidarity ... HC-nCoV ... Zhaowei Chen Coalition Covid-19 Brazil I ... NCT04333654 FACCT Trial Dubee Kamran
darunavir cobicistat Jun C
Emtricitabine/tenofovir plus colchicine plus rosuvastatin Gaitan-Duarte ...
Ensitrelvir (XOCOVA) Mukae - Phase 2a
favipiravir IRCT20200428047228N1 // U07 Udwadia AVIFAVIR Lou ... Chang Chen et al. NCT04310228-FAVI ... jRCTs041190120 IRCT20150808023559N20 IRCT20150808023559N20 Dabbous HM Holubar M IRCT20151227025726N14 // U07 FACCT Trial Udwadia AVIFAVIR Shenoy S NCT04542694 Ruzhentsova T Solaymani-Dodaran Shinkai
favipiravir plus interferon Khamis
hydroxychloroquine plus macrolides Duke university HCQ-AZI
azithromycin plus hydroxychloroquine ProPAC-COVID Coalition Covid-19 Brazil I ...
ivermectin Gonzalez ... Shahbaznejad Ahmed Chachar Chaccour Bukhari Kirti Babalola RIVET-COV ... Abd-Elsalam Krolewiecki I-TECH ... Mayer
ivermectin plus doxycycline Hashim A NCT04523831 ...
lopinavir/ritonavir RECOVERY SOLIDARITY ... Nojomi Ader ... ELACOI ...
lopinavir/ritonavir plus interferon ß-1a Ader ...
lopinavir/ritonavir, ribavirin and interferon beta-1b Hung et al.
niclosamide Abdulamir
nirmatrelvir / ritonavir (Paxlovid) EPIC-SR
nitazoxanide Rocco Silva Fontanesi
opaganib Winthrop
remdesivir NIH NIAID ACTT-1 DisCoVeRy ... SOLIDARITY ... Mahajan Norwegian NOR study ... Andreas ... GS-US-540-5774, 10 days GS-US-540-5774, 5 days GS-US-540-5773 ...
sofosbuvir Sali Alavi-moghaddam
sofosbuvir and daclatasvir Sadeghi Yakoot Mobarak S ... Mobarak ...
sofosbuvir and ledipasvir Elgohary Nourian A
tenofovir/emtricitabine Gaitan-Duarte ...
umifenovir (arbidol) UAIIC Nojomi ELACOI ... Yethindra ELACOI ...
zinc Patel
Drugs for acid related disorders
H2 blockers
famotidine Samimagham
miscellaneous
Aspirin RECOVERY ...
aviptadil COVID-AIV
camostat mesilate Gunst JD
Cannabidiol Crippa ...
honey Silveira
povidone-iodine Mohamed
sabizabulin VERU-111
Oral antidiabetic drugs
dapagliflozin DARE-19
DPP-4 inhibitor Guardado-Mendoza
Renin-angiotensin-system-acting agents
angiotensin receptor blockers (ARBs) Duarte Nouri-Vaskeh
losartan University of Minnesota
discontinuation of ACEI/ARB REPLACE Najmeddin Lopes ...
Vitamins
Vitamin D Entrenas ... Murai Rastogi
hight dose vitamin D COVIT-TRIAL

0 studies excluded by filtering options 1

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons